The current financial score of GE Healthcare Technologies Inc is 8.02. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 5.29B, representing a year-over-year increase of 5.75%, while its net profit experienced a year-over-year increase of 15.43%.
The current valuation score of GE Healthcare Technologies Inc is 9.44. Its current P/E ratio is 15.26, which is 102.07% below the recent high of 30.84 and 19.54% above the recent low of 12.28.
The current earnings forecast score of GE Healthcare Technologies Inc is 7.82. The average price target is 83.64, with a high of 96.00 and a low of 71.00.
The current price momentum score of GE Healthcare Technologies Inc is 3.54. Currently, the stock price is trading between the resistance level at 71.98 and the support level at 59.55, making it suitable for range-bound swing trading.
The current institutional shareholding score of GE Healthcare Technologies Inc is 10.00. The latest institutional shareholding proportion is 93.61%, representing a quarter-over-quarter increase of 9.22%. The largest institutional shareholder is Barrow Hanley, holding a total of 13.46M shares, representing 2.61% of shares outstanding, with 46.96% increase in holdings.
The current risk assessment score of GE Healthcare Technologies Inc is 7.76. The company's beta value is 0.87. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.